Mannose-capped lipoarabinomannan-induced B10 cells decrease severity of dextran sodium sulfate-induced inflammatory bowel disease in mice.
Mannose-capped lipoarabinomannan-induced B10 cells decrease severity of dextran sodium sulfate-induced inflammatory bowel disease in mice.
复制标题
甘露糖封端的阿拉伯脂甘露聚糖诱导的 B10 细胞可降低右旋糖酐硫酸钠诱导的小鼠炎症性肠病的严重程度。
DOI:
10.1111/sji.12843
复制
发表时间:
2019
影响因子:
3.7
通讯作者:
Pan Qin
中科院分区:
文献类型:
--
作者:
Yuan Chunhui;Li Xin;Luo Liang;Wang Yaping;Zhang Dongli;Zhou Kai Liang;Zhang Xiao-Lian;Pan Qin
Inflammatory bowel disease (IBD) is a chronic, non‐specific, inflammatory gastrointestinal disease that mainly consists of Crohn's disease and ulcerative colitis. However, the aetiology and pathogenesis of IBD are still unclear. B10 (IL‐10 producing regulatory B) cells, a subset of regulatory B cells, are known to contribute to intestinal homeostasis and the aberrant frequency of B10 cells is associated with IBD. We have recently reported that B10 cells can be induced by ManLAM (mannose‐capped lipoarabinomannan), a major cell‐wall lipoglycan ofM tb(Mycobacterium tuberculosis). In the current study, the ManLAM‐induced B10 cells were adoptively transferred into IL(interleukin)‐10−/−mice and the roles of ManLAM‐induced B10 cells were investigated in DSS (dextran sodium sulphate)‐induced IBD model. ManLAM‐induced B10 cells decrease colitis severity in the mice. The B10 cells downregulate Th1 polarization in spleen and MLNs (mesenteric lymph nodes) of DSS‐treated mice. These results suggest that IL‐10 production by ManLAM‐treated B cells contributes to keeping the balance between CD4+T cell subsets and protect mice from DSS‐induced IBD.